Regulatory circuitries coordinated by transcription factors and microRNAs at the cornerstone of hematopoietic stem cell self-renewal and differentiation

Current Stem Cell Research and Therapy

Volumn 6, Issue 2, 2011, Pages 142-161

  Starnes, Linda M ^a,b   Sorrentino, Antonio ^c,d  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b San Raffaele Biomedical Park Foundation   (Italy)

^c ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Hematopoiesis; Hematopoietic stem cell; MicroRNAs; Transcription factors

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN ALPHA; ERYTHROID KRUPPEL LIKE FACTOR; LIM KINASE; MICRORNA; NUCLEAR FACTOR I; NUCLEAR FACTOR I A; PROTEIN C MYB; PROTEIN GFI 1; PROTEIN GFI 1B; PROTEIN LDB1; PROTEIN LMO2; PROTEIN LYL 1; PROTEIN PLZF; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR E2A; TRANSCRIPTION FACTOR ERG; TRANSCRIPTION FACTOR ETV6; TRANSCRIPTION FACTOR FKHR; TRANSCRIPTION FACTOR FLI 1; TRANSCRIPTION FACTOR GATA 1; TRANSCRIPTION FACTOR GATA 2; TRANSCRIPTION FACTOR JUNB; TRANSCRIPTION FACTOR MAFB; TRANSCRIPTION FACTOR NF E2; TRANSCRIPTION FACTOR PU 1; TRANSCRIPTION FACTOR RUNX1; TRANSCRIPTION FACTOR SOX7; TRANSCRIPTION FACTOR TAL1; UNCLASSIFIED DRUG; UNINDEXED DRUG; ZINC FINGER PROTEIN;

AMINO ACID SEQUENCE; ARTICLE; CELL DIFFERENTIATION; CELL GROWTH; CELL LINEAGE; ERYTHROPOIESIS; GENE EXPRESSION; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HOMEOSTASIS; MEGAKARYOPOIESIS; MYELOPOIESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ANIMALS; CELL DIFFERENTIATION; GENE EXPRESSION REGULATION; HEMATOPOIESIS; HEMATOPOIETIC STEM CELLS; HUMANS; MICRORNAS; TRANSCRIPTION FACTORS;

EID: 79955692569     PISSN: 1574888X     EISSN: None     Source Type: Journal    
DOI: 10.2174/157488811795495431     Document Type: Article

References (317)

1. Tavian M, Peault B. Embryonic development of the human hematopoietic system. Int J Dev Biol 2005; 49: 243-50.
2. Tavian M, Peault B. Analysis of hematopoietic development during human embryonic ontogenesis. Methods Mol Med 2005; 105: 413-24.
3. Tavian M, Peault B. The changing cellular environments of hematopoiesis in human development in utero. Exp Hematol 2005; 33:1062-9.
4. Palis J, Yoder MC. Yolk-sac hematopoiesis: the first blood cells of mouse and man. Exp Hematol 2001; 29: 927-36.
5. Dzierzak E, Speck NA. Of lineage and legacy: the development of mammalian hematopoietic stem cells. Nat Immunol 2008; 9: 129-36.
6. Medvinsky A, Dzierzak E. Definitive hematopoiesis is autonomously initiated by the AGM region. Cell 1996; 86: 897-906.
7. de Bruijn MF, Ma X, Robin C, Ottersbach K, Sanchez MJ, Dzierzak E. Hematopoietic stem cells localize to the endothelial cell layer in the midgestation mouse aorta. Immunity 2002; 16: 673-83.
8. de Bruijn MF, Speck NA, Peeters MC, Dzierzak E. Definitive hematopoietic stem cells first develop within the major arterial regions of the mouse embryo. EMBO J 2000; 19: 2465-74.
9. Rhodes KE, Gekas C, Wang Y, et al. The emergence of hematopoietic stem cells is initiated in the placental vasculature in the absence of circulation. Cell Stem Cell 2008; 2: 252-63.
10. Mikkola HK, Orkin SH. The journey of developing hematopoietic stem cells. Development 2006; 133: 3733-44.
11. Weissman IL. Stem cells: units of development, units of regeneration, and units in evolution. Cell 2000; 100: 157-68.
12. Orkin SH, Zon LI. Hematopoiesis: an evolving paradigm for stem cell biology. Cell 2008; 132: 631-44.
13. Bonifer C, Hoogenkamp M, Krysinska H, Tagoh H. How transcription factors program chromatin--lessons from studies of the regulation of myeloid-specific genes. Semin Immunol 2008; 20: 257-63.
14. Gottgens B, Barton LM, Chapman MA, et al. Transcriptional regulation of the stem cell leukemia gene (SCL)--comparative analysis of five vertebrate SCL loci. Genome Res 2002; 12: 749-59.
15. Gottgens B, Broccardo C, Sanchez MJ, et al. The scl +18/19 stem cell enhancer is not required for hematopoiesis: identification of a5' bi-functional hematopoietic-endothelial enhancer bound by Fli-1and Elf-1. Mol Cell Biol 2004; 24: 1870-83.
16. Pimanda JE, Ottersbach K, Knezevic K, et al. Gata2, Fli1, and Scl form a recursively wired gene-regulatory circuit during early hematopoietic development. Proc Natl Acad Sci USA 2007; 104: 17692-7.
17. Bee T, Ashley EL, Bickley SR, et al. The mouse Runx1 +23 hematopoietic stem cell enhancer confers hematopoietic specificity to both Runx1 promoters. Blood 2009; 113: 5121-4.
18. Lemischka IR, Pritsker M. Alternative splicing increases complexity of stem cell transcriptome. Cell Cycle 2006; 5: 347-51.
19. He L, Hannon GJ. MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet 2004; 5: 522-31.
20. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116: 281-97.
21. Ambros V. The functions of animal microRNAs. Nature 2004; 431:350-5.
22. Faloon P, Arentson E, Kazarov A, et al. Basic fibroblast growth factor positively regulates hematopoietic development. Development 2000; 127: 1931-41.
23. Shalaby F, Rossant J, Yamaguchi TP, et al. Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature 1995;376: 62-6.
24. Winnier G, Blessing M, Labosky PA, Hogan BL. Bone morphogenetic protein-4 is required for mesoderm formation and patterning in the mouse. Genes Dev 1995; 9: 2105-16.
25. Lee CY, Vogeli KM, Kim SH, et al. Notch signaling functions as a cell-fate switch between the endothelial and hematopoietic lineages. Curr Biol 2009; 19: 1616-22.
26. North T, Gu TL, Stacy T, et al. Cbfa2 is required for the formation of intra-aortic hematopoietic clusters. Development 1999; 126:2563-75.
27. de Bruijn MF, Speck NA. Core-binding factors in hematopoiesis and immune function. Oncogene 2004; 23: 4238-48.
28. Wang Q, Stacy T, Binder M, Marin-Padilla M, Sharpe AH, Speck NA. Disruption of the Cbfa2 gene causes necrosis and hemorrhaging in the central nervous system and blocks definitive hematopoiesis. Proc Natl Acad Sci USA 1996; 93: 3444-9.
29. Cai Z, de Bruijn M, Ma X, et al. Haploin sufficiency of AML1 affects the temporal and spatial generation of hematopoietic stem cells in the mouse embryo. Immunity 2000; 13: 423-31.
30. Okuda T, van Deursen J, Hiebert SW, Grosveld G, Downing JR.AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis. Cell 1996; 84: 321-30.
31. North TE, de Bruijn MF, Stacy T, et al. Runx1 expression marks long-term repopulating hematopoietic stem cells in the midgestation mouse embryo. Immunity 2002; 16: 661-72.
32. Chen MJ, Yokomizo T, Zeigler BM, Dzierzak E, Speck NA.Runx1 is required for the endothelial to haematopoietic cell transition but not thereafter. Nature 2009; 457: 887-91.
33. Dowdy CR, Xie R, Frederick D, et al. Definitive hematopoiesis requires Runx1 C-terminal-mediated sub nuclear targeting and transactivation. Hum Mol Genet 2010; 19(6): 1048-57.
34. Tsai FY, Keller G, Kuo FC, et al. An early haematopoietic defect in mice lacking the transcription factor GATA-2. Nature 1994; 371:221-6.
35. Rodrigues NP, Janzen V, Forkert R, et al. Haploinsufficiency of GATA-2 perturbs adult hematopoietic stem-Cell homeostasis.Blood 2005; 106: 477-84.
36. Shivdasani RA, Mayer EL, Orkin SH. Absence of blood formation in mice lacking the T-Cell leukaemia on coprotein tal-1/SCL. Nature 1995; 373: 432-4.
37. Warren AJ, Colledge WH, Carlton MB, Evans MJ, Smith AJ, Rabbitts TH. The oncogenic cysteine-rich LIM domain protein rbtn2 is essential for erythroid development. Cell 1994; 78: 45-57.
38. Yamada Y, Warren AJ, Dobson C, Forster A, Pannell R, Rabbitts TH. The T cell leukemia LIM protein Lmo2 is necessary for adult mouse hematopoiesis. Proc Natl Acad Sci USA 1998; 95: 3890-5.
39. Hart A, Melet F, Grossfeld P, et al. Fli-1 is required for murine vascular and megakaryocytic development and is hemizygously deleted in patients with thrombocytopenia. Immunity 2000; 13: 167-77.
40. Spyropoulos DD, Pharr PN, Lavenburg KR, et al. Hemorrhage,impaired hematopoiesis, and lethality in mouse embryos carrying a targeted disruption of the Fli1 transcription factor. Mol Cell Biol 2000; 20: 5643-52.
41. Liu F, Walmsley M, Rodaway A, Patient R. Fli1 acts at the top of the transcriptional network driving blood and endothelial development. Curr Biol 2008; 18: 1234-40.
42. Cheshier SH, Morrison SJ, Liao X, Weissman IL. in vivo proliferation and cell cycle kinetics of long-term self-renewing hematopoietic stem cells. Proc Natl Acad Sci USA 1999; 96: 3120-5.
43. Garrett RW, Emerson SG. Bone and blood vessels: the hard and the soft of hematopoietic stem cell niches. Cell Stem Cell 2009; 4: 503-6.
44. Kiel MJ, Morrison SJ. Uncertainty in the niches that maintain haematopoietic stem cells. Nat Rev Immunol 2008; 8: 290-301.
45. Mullighan CG, Goorha S, Radtke I, et al. Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia. Nature 2007;446: 758-64.
46. Marcucci G, Maharry K, Whitman SP, et al. High expression levels of the ETS-related gene, ERG, predict adverse outcome and improve molecular risk-based classification of cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B Study. J Clin Oncol 2007; 25: 3337-43.
47. Loughran SJ, Kruse EA, Hacking DF, et al. The transcription factor Erg is essential for definitive hematopoiesis and the function of adult hematopoietic stem cells. Nat Immunol 2008; 9: 810-9.
48. Salek-Ardakani S, Smooha G, de Boer J, et al. ERG is a megakaryocytic oncogene. Cancer Res 2009; 69: 4665-73.
49. Kruse EA, Loughran SJ, Baldwin TM, et al. Dual requirement for the ETS transcription factors Fli-1 and Erg in hematopoietic stem cells and the megakaryocyte lineage. Proc Natl Acad Sci USA 2009; 106: 13814-9.
50. Hock H, Meade E, Medeiros S, et al. Tel/Etv6 is an essential and selective regulator of adult hematopoietic stem cell survival. Genes Dev 2004; 18: 2336-41.
51. Mikkola HK, Klintman J, Yang H, et al. Haematopoietic stem cell sretain long-term repopulating activity and multipotency in the absence of stem-cell leukaemia SCL/tal-1 gene. Nature 2003; 421:547-51.
52. Curtis DJ, Hall MA, Van Stekelenburg LJ, Robb L, Jane SM, Begley CG. SCL is required for normal function of short-term re-populating hematopoietic stem cells. Blood 2004; 103: 3342-8.
53. Lacombe J, Herblot S, Rojas-Sutterlin S, et al. Scl regulates the quiescence and the long-term competence of hematopoietic stem cells. Blood 2010; 115(4): 792-803
54. Giroux S, Kaushik AL, Capron C, et al. lyl-1 and tal-1/scl, two genes encoding closely related bHLH transcription factors, display highly overlapping expression patterns during cardiovascular and hematopoietic ontogeny. Gene Expr Patterns 2007; 7: 215-26.
55. Capron C, Lecluse Y, Kaushik AL, et al. The SCL relative LYL-1is required for fetal and adult hematopoietic stem cell function and B-cell differentiation. Blood 2006; 107: 4678-86.
56. Souroullas GP, Salmon JM, Sablitzky F, Curtis DJ, Goodell MA. Adult hematopoietic stem and progenitor cells require either Lyl1or Scl for survival. Cell Stem Cell 2009; 4: 180-6.
57. Wilson NK, Miranda-Saavedra D, Kinston S, et al. The transcriptional program controlled by the stem cell leukemia gene Scl/Tal1 during early embryonic hematopoietic development. Blood 2009;113: 5456-65.
58. Passegue E, Wagner EF, Weissman IL. Jun B deficiency leads to a myeloproliferative disorder arising from hematopoietic stem cells. Cell 2004; 119: 431-43.
59. Santaguida M, Schepers K, King B, et al. Jun B protects against myeloid malignancies by limiting hematopoietic stem cell proliferation and differentiation without affecting self-renewal. Cancer Cell 2009; 15: 341-52.
60. Mucenski ML, Taylor BA, Ihle JN, et al. Identification of a common ecotropic viral integration site, Evi-1, in the DNA of AKXD murine myeloid tumors. Mol Cell Biol 1988; 8: 301-8.
61. Ogawa S, Mitani K, Kurokawa M, et al. Abnormal expression ofEvi-1 gene in human leukemias. Hum Cell 1996; 9: 323-32.
62. Suzukawa K, Parganas E, Gajjar A, et al. Identification of a break-point cluster region 3' of the ribophorin I gene at 3q21 associated with the transcriptional activation of the EVI1 gene in acute mye-logenous leuk emias with inv(3)(q21q26). Blood 1994; 84: 2681-8.
63. Goyama S, Yamamoto G, Shimabe M, et al. Evi-1 is a critical regulator for hematopoietic stem cells and transformed leukemic cells. Cell Stem Cell 2008; 3: 207-20.
64. Krishnaraju K, Hoffman B, Liebermann DA. Early growth response gene 1 stimulates development of hematopoietic progenitor cells along the macrophage lineage at the expense of the granulocyte and erythroid lineages. Blood 2001; 97: 1298-305.
65. Min IM, Pietramaggiori G, Kim FS, Passegue E, Stevenson KE, Wagers AJ. The transcription factor EGR1 controls both the proliferation and localization of hematopoietic stem cells. Cell Stem Cell 2008; 2: 380-91.
66. Tothova Z, Kollipara R, Huntly BJ, et al. FoxOs are critical mediators of hematopoietic stem cell resistance to physiologic oxidative stress. Cell 2007; 128: 325-39.
67. Miyamoto K, Araki KY, Naka K, et al. Foxo3a is essential for maintenance of the hematopoietic stem cell pool. Cell Stem Cell 2007; 1: 101-12.
68. Abramovich C, Pineault N, Ohta H, Humphries RK. Hox genes: from leukemia to hematopoietic stem cell expansion. Ann N Y Acad Sci 2005; 1044: 109-16.
69. Antonchuk J, Sauvageau G, Humphries RK. HOXB4 over expression mediates very rapid stem cell regeneration and competitive hematopoietic repopulation. Exp Hematol 2001; 29: 1125-34.
70. Krosl J, Beslu N, Mayotte N, Humphries RK, Sauvageau G. The competitive nature of HOXB4-transduced HSC is limited byPBX1: the generation of ultra-competitive stem cells retaining full differentiation potential. Immunity 2003; 18: 561-71.
71. Ficara F, Murphy MJ, Lin M, Cleary ML. Pbx1 regulates self renewal of long-term hematopoietic stem cells by maintaining their quiescence. Cell Stem Cell 2008; 2: 484-96.
72. Schiedlmeier B, Santos AC, Ribeiro A, et al. HOXB4's road map to stem cell expansion. Proc Natl Acad Sci USA 2007; 104: 16952-7.
73. Lawrence HJ, Christensen J, Fong S, et al. Loss of expression of the Hoxa-9 homeobox gene impairs the proliferation and repopulating ability of hematopoietic stem cells. Blood 2005; 106: 3988-94.
74. Hu YL, Fong S, Ferrell C, Largman C, Shen WF. HOXA9 modulates its oncogenic partner Meis1 to influence normal hematopoiesis. Mol Cell Biol 2009; 29: 5181-92.
75. Shen WF, Hu YL, Uttarwar L, Passegue E, Largman C. MicroRNA-126 regulates HOXA9 by binding to the homeobox. Mol Cell Biol 2008; 28: 4609-19.
76. Gangaraju VK, Lin H. MicroRNAs: key regulators of stem cells. Nat Rev Mol Cell Biol 2009; 10: 116-25.
77. Georgantas RW 3rd, Hildreth R, Morisot S, et al. CD34+ hematopoietic stem-progenitor cell microRNA expression and function: a circuit diagram of differentiation control. Proc Natl Acad Sci USA 2007; 104: 2750-5.
78. Iwasaki H, Akashi K. Myeloid lineage commitment from the hematopoietic stem cell. Immunity 2007; 26: 726-40.
79. Cross MA, Enver T. The lineage commitment of haemopoietic progenitor cells. Curr Opin Genet Dev 1997; 7: 609-13.
80. Gargiulo G, Levy S, Bucci G, et al. NA-Seq: a discovery tool for the analysis of chromatin structure and dynamics during differentiation. Dev Cell 2009; 16: 466-81.
81. Miyamoto T, Iwasaki H, Reizis B, et al. Myeloid or lymphoid promiscuity as a critical step in hematopoietic lineage commitment. Dev Cell 2002; 3: 137-47.
82. Arinobu Y, Mizuno S, Chong Y, et al. Reciprocal activation of GATA-1 and PU.1 marks initial specification of hematopoietic stem cells into myeloerythroid and myelolymphoid lineages. Cell Stem Cell 2007; 1: 416-27.
83. Rekhtman N, Radparvar F, Evans T, Skoultchi AI. Direct interaction of hematopoietic transcription factors PU.1 and GATA-1: functional antagonism in erythroid cells. Genes Dev 1999; 13:1398-411.
84. Nerlov C, Querfurth E, Kulessa H, Graf T. GATA-1 interacts with the myeloid PU.1 transcription factor and represses PU.1-dependent transcription. Blood 2000; 95: 2543-51.
85. Chou ST, Khandros E, Bailey LC, et al. Graded repression of PU.1/Sfpi1 gene transcription by GATA factors regulates hematopoietic cell fate. Blood 2009; 114: 983-94.
86. Zhang P, Zhang X, Iwama A, et al. PU.1 inhibits GATA-1 function and erythroid differentiation by blocking GATA-1 DNA binding. Blood 2000; 96: 2641-8.
87. Stopka T, Amanatullah DF, Papetti M, Skoultchi AI. PU.1 inhibits the erythroid program by binding to GATA-1 on DNA and creating a repressive chromatin structure. EMBO J 2005; 24: 3712-23.
88. Wang X, Crispino JD, Letting DL, Nakazawa M, Poncz M, BlobelGA. Control of megakaryocyte-specific gene expression by GATA-1 and FOG-1: role of Ets transcription factors. EMBO J 2002; 21:5225-34.
89. Merika M, Orkin SH. Functional synergy and physical interactions of the erythroid transcription factor GATA-1 with the Kruppel family proteins Sp1 and EKLF. Mol Cell Biol 1995; 15: 2437-47.
90. Frontelo P, Manwani D, Galdass M, et al. Novel role for EKLF in megakaryocyte lineage commitment. Blood 2007; 110: 3871-80.
91. Starck J, Cohet N, Gonnet C, et al. Functional cross-antagonism between transcription factors FLI-1 and EKLF. Mol Cell Biol 2003; 23: 1390-402.
92. Bouilloux F, Juban G, Cohet N, et al. EKLF restricts megakaryocytic differentiation at the benefit of erythrocytic differentiation. Blood 2008; 112: 576-84.
93. Oh IH, Reddy EP. The myb gene family in cell growth, differentiation and apoptosis. Oncogene 1999; 18: 3017-33.
94. Greig KT, Carotta S, Nutt SL. Critical roles for c-Myb in hema-topoietic progenitor cells. Semin Immunol 2008; 20: 247-56.
95. Mucenski ML, McLain K, Kier AB, et al. A functional c-myb geneis required for normal murine fetal hepatic hematopoiesis. Cell 1991; 65: 677-89.
96. Vegiopoulos A, Garcia P, Emambokus N, Frampton J. Coordination of erythropoiesis by the transcription factor c-Myb. Blood 2006; 107: 4703-10.
97. Lieu YK, Reddy EP. Conditional c-myb knockout in adult hematopoietic stem cells leads to loss of self-renewal due to impaired proliferation and accelerated differentiation. Proc Natl Acad Sci USA 2009; 106(51): 21689-94.
98. Garcia P, Clarke M, Vegiopoulos A, et al. Reduced c-Myb activity compromises HSCs and leads to a myeloproliferation with a novel stem cell basis. EMBO J 2009; 28: 1492-504.
99. Sandberg ML, Sutton SE, Pletcher MT, et al. C-Myb and p300regulate hematopoietic stem cell proliferation and differentiation. Dev Cell 2005; 8: 153-66.
100. Emambokus N, Vegiopoulos A, Harman B, Jenkinson E, Anderson G, Frampton J. Progression through key stages of haemopoiesis is dependent on distinct threshold levels of c-Myb. EMBO J 2003;22: 4478-88.
101. Mukai HY, Motohashi H, Ohneda O, Suzuki N, Nagano M, Yamamoto M. Transgene insertion in proximity to the c-myb gene disrupts erythroid-megakaryocytic lineage bifurcation. Mol Cell Biol 2006; 26: 7953-65.
102. Lu J, Guo S, Ebert BL, et al. MicroRNA-mediated control of cell fate in megakaryocyte-erythrocyte progenitors. Dev Cell 2008; 14:843-53.
103. Zhao H, Kalota A, Jin S, Gewirtz AM. The c-myb proto-oncogene and microRNA-15a comprise an active auto regulatory feedback loop in human hematopoietic cells. Blood 2009; 113: 505-16.
104. Navarro F, Gutman D, Meire E, et al. miR-34a contributes to megakaryocytic differentiation of K562 cells independently of p53. Blood 2009; 114: 2181-92.
105. Crispino JD. GATA1 in normal and malignant hematopoiesis. Semin Cell Dev Biol 2005; 16: 137-47.
106. Shimizu R, Engel JD, Yamamoto M. GATA1-related leukaemias. Nat Rev Cancer 2008; 8: 279-87.
107. Ferreira R, Ohneda K, Yamamoto M, Philipsen S. GATA1 function, a paradigm for transcription factors in hematopoiesis. Mol Cell Biol 2005; 25: 1215-27.
108. Fujiwara Y, Browne CP, Cunniff K, Goff SC, Orkin SH. Arrested development of embryonic red cell precursors in mouse embryos lacking transcription factor GATA-1. Proc Natl Acad Sci USA 1996; 93: 12355-8.
109. Weiss MJ, Keller G, Orkin SH. Novel insights into erythroid development revealed through in vitro differentiation of GATA-1embryonic stem cells. Genes Dev 1994; 8: 1184-97.
110. Shivdasani RA, Fujiwara Y, McDevitt MA, Orkin SH. A lineage-selective knockout establishes the critical role of transcription factor GATA-1 in megakaryocyte growth and platelet development. EMBO J 1997; 16: 3965-73.
111. Heyworth C, Pearson S, May G, Enver T. Transcription factor mediated lineage switching reveals plasticity in primary committed progenitor cells. EMBO J 2002; 21: 3770-81.
112. Iwasaki H, Mizuno S, Wells RA, Cantor AB, Watanabe S, Akashi K. GATA-1 converts lymphoid and myelomonocytic progenitors into the megakaryocyte/erythrocyte lineages. Immunity 2003; 19:451-62.
113. Welch JJ, Watts JA, Vakoc CR, et al. Global regulation of erythroid gene expression by transcription factor GATA-1. Blood 2004; 104: 3136-47.
114. Vyas P, Ault K, Jackson CW, Orkin SH, Shivdasani RA. Consequences of GATA-1 deficiency in megakaryocytes and platelets. Blood 1999; 93: 2867-75.
115. Rodriguez P, Bonte E, Krijgsveld J, et al. GATA-1 forms distinctactivating and repressive complexes in erythroid cells. EMBO J 2005; 24: 2354-66.
116. Johnson KD, Kim SI, Bresnick EH. Differential sensitivities of transcription factor target genes underlie cell type-specific gene expression profiles. Proc Natl Acad Sci USA 2006; 103: 15939-44.
117. Cheng Y, Wu W, Kumar SA, et al. Erythroid GATA1 function revealed by genome-wide analysis of transcription factor occupancy, histone modifications, and mRNA expression. Genome Res 2009; 19: 2172-84.
118. Yu M, Riva L, Xie H, et al. Insights into GATA-1-mediated gene activation versus repression via genome-wide chromatin occupancy analysis. Mol Cell 2009; 36: 682-95.
119. Fujiwara T, O'Geen H, Keles S, et al. Discovering hematopoietic mechanisms through genome-wide analysis of GATA factor chromatin occupancy. Mol Cell 2009; 36: 667-81.
120. Zhang Y, Wu W, Cheng Y, et al. Primary sequence and epigenetic determinants of in vivo occupancy of genomic DNA by GATA1. Nucleic Acids Res 2009; 37: 7024-38.
121. Steiner LA, Maksimova Y, Schulz V, et al. Chromatin architecture and transcription factor binding regulate expression of erythrocyte membrane protein genes. Mol Cell Biol 2009; 29: 5399-412.
122. Tripic T, Deng W, Cheng Y, et al. SCL and associated proteins distinguish active from repressive GATA transcription factor complexes. Blood 2009; 113: 2191-201.
123. Grass JA, Boyer ME, Pal S, Wu J, Weiss MJ, Bresnick EH. GATA-1-dependent transcriptional repression of GATA-2 via disruption of positive auto regulation and domain-wide chromatin remodeling. Proc Natl Acad Sci USA 2003; 100: 8811-6.
124. Martowicz ML, Grass JA, Boyer ME, Guend H, Bresnick EH. Dynamic GATA factor interplay at a multi-component regulatory region of the GATA-2 locus. J Biol Chem 2005; 280: 1724-32.
125. Lurie LJ, Boyer ME, Grass JA, Bresnick EH. Differential GATA factor stabilities: implications for chromatin occupancy by structurally similar transcription factors. Biochemistry (Mosc) 2008; 47:859-69.
126. Hamlett I, Draper J, Strouboulis J, Iborra F, Porcher C, Vyas P. Characterization of megakaryocyte GATA1-interacting proteins: the corepressor ETO2 and GATA1 interact to regulate terminal megakaryocyte maturation. Blood 2008; 112: 2738-49.
127. Trainor CD, Mas C, Archambault P, Di Lello P, Omichinski JG. GATA-1 associates with and inhibits p53. Blood 2009; 114: 165-73.
128. Kadri Z, Shimizu R, Ohneda O, et al. Direct binding of pRb/E2F-2to GATA-1 regulates maturation and terminal cell division during erythropoiesis. PLoS Biol 2009; 7: e1000123.
129. Gregory T, Yu C, Ma A, Orkin SH, Blobel GA, Weiss MJ. GATA-1 and erythropoietin cooperate to promote erythroid cell survival by regulating bcl-xL expression. Blood 1999; 94: 87-96.
130. Maeda T, Ito K, Merghoub T, et al. LRF is an essential down stream target of GATA1 in erythroid development and regulates BIM-dependent apoptosis. Dev Cell 2009; 17: 527-40.
131. Muntean AG, Pang L, Poncz M, Dowdy SF, Blobel GA, Crispino JD. Cyclin D-Cdk4 is regulated by GATA-1 and required for megakaryocyte growth and polyploidization. Blood 2007; 109:5199-207.
132. Lowry JA, Mackay JP. GATA-1: one protein, many partners. Int J Biochem Cell Biol 2006; 38: 6-11.
133. Matsubara E, Sakai I, Yamanouchi J, et al. The role of zinc finger protein 521/early hematopoietic zinc finger protein in erythroid cell differentiation. J Biol Chem 2009; 284: 3480-7.
134. Woo AJ, Moran TB, Schindler YL, et al. Identification of ZBP-89as a novel GATA-1-associated transcription factor involved in megakaryocytic and erythroid development. Mol Cell Biol 2008;28: 2675-89.
135. Fox AH, Liew C, Holmes M, Kowalski K, Mackay J, Crossley M. Transcriptional cofactors of the FOG family interact with GATA proteins by means of multiple zinc fingers. EMBO J 1999; 18:2812-22.
136. Tsang AP, Fujiwara Y, Hom DB, Orkin SH. Failure of mega-karyopoiesis and arrested erythropoiesis in mice lacking theGATA-1 transcriptional cofactor FOG. Genes Dev 1998; 12: 1176-88.
137. Miccio A, Wang Y, Hong W, et al. NuRD mediates activating and repressive functions of GATA-1 and FOG-1 during blood development. EMBO J 2010; 29(2): 442-56.
138. Gao Z, Huang Z, Olivey HE, Gurbuxani S, Crispino JD, Svensson EC. FOG-1-mediated recruitment of NuRD is required for cell lineage re-enforcement during haematopoiesis. EMBO J 2009;
139. Snow JW, Orkin SH. Translational isoforms of FOG1 regulateGATA1-interacting complexes. J Biol Chem 2009; 284: 29310-9.
140. Growney JD, Shigematsu H, Li Z, et al. Loss of Runx1 perturbs adult hematopoiesis and is associated with a myeloproliferative phenotype. Blood 2005; 106: 494-504.
141. Song WJ, Sullivan MG, Legare RD, et al. Haploinsufficiency ofCBFA2 causes familial thrombocytopenia with propensity to developacute myelogenous leukaemia. Nat Genet 1999; 23: 166-75.
142. Elagib KE, Racke FK, Mogass M, Khetawat R, Delehanty LL, Goldfarb AN. RUNX1 and GATA-1 coexpression and cooperation in megakaryocytic differentiation. Blood 2003; 101: 4333-41.
143. Elagib KE, Mihaylov IS, Delehanty LL, et al. Cross-talk of GATA-1 and P-TEFb in megakaryocyte differentiation. Blood 2008; 112:4884-94.
144. Goldfarb AN. Megakaryocytic programming by a transcriptional regulatory loop: A circle connecting RUNX1, GATA-1, and PTEFb.J Cell Biochem 2009; 107: 377-82.
145. Ben-Ami O, Pencovich N, Lotem J, Levanon D, Groner Y. A regulatory interplay between miR-27a and Runx1 during megakaryopoiesis. Proc Natl Acad Sci USA 2009; 106: 238-43.
146. Raslova H, Komura E, Le Couedic JP, et al. FLI1 monoallelic expression combined with its hemizygous loss underlies Paris-Trousseau/Jacobsen thrombopenia. J Clin Invest 2004; 114: 77-84.
147. Huang H, Yu M, Akie TE, et al. Differentiation-dependent interactions between RUNX-1 and FLI-1 during megakaryocyte development. Mol Cell Biol 2009; 29: 4103-15.
148. Dore LC, Amigo JD, Dos Santos CO, et al. A GATA-1-regulated microRNA locus essential for erythropoiesis. Proc Natl Acad Sci USA 2008; 105: 3333-8.
149. Fu YF, Du TT, Dong M, et al. Mir-144 selectively regulates embryonicalpha-hemoglobin synthesis during primitive erythropoiesis. Blood 2009; 113: 1340-9.
150. Pase L, Layton JE, Kloosterman WP, Carradice D, Waterhouse PM, Lieschke GJ. miR-451 regulates zebrafish erythroid maturationin vivo via its target gata2. Blood 2009; 113: 1794-804.
151. Chen Q, Cheng JT, Tasi LH, et al. The tal gene undergoes chromosometrans location in T cell leukemia and potentially encodes a helix-loop-helix protein. EMBO J 1990; 9: 415-24.
152. Finger LR, Kagan J, Christopher G, et al. Involvement of the TCL5gene on human chromosome 1 in T-cell leukemia and melanoma. Proc Natl Acad Sci USA 1989; 86: 5039-43.
153. Palomero T, Odom DT, O'Neil J, et al. Transcriptional regulatory networks down stream of TAL1/SCL in T-cell acute lymphoblastic leukemia. Blood 2006; 108: 986-92.
154. Elwood NJ, Zogos H, Pereira DS, Dick JE, Begley CG. Enhanced megakaryocyte and erythroid development from normal human CD34(+) cells: consequence of enforced expression of SCL. Blood 1998; 91: 3756-65.
155. Aplan PD, Nakahara K, Orkin SH, Kirsch IR. The SCL gene product: a positive regulator of erythroid differentiation. EMBO J 1992; 11: 4073-81.
156. Hall MA, Curtis DJ, Metcalf D, et al. The critical regulator ofembryonic hematopoiesis, SCL, is vital in the adult for megakaryopoiesis, erythropoiesis, and lineage choice in CFU-S12. Proc Natl Acad Sci USA 2003; 100: 992-7.
157. Schlaeger TM, Mikkola HK, Gekas C, Helgadottir HB, Orkin SH.Tie2Cre-mediated gene ablation defines the stem-cell leukemiagene (SCL/tal1)-dependent window during hematopoietic stem-celldevelopment. Blood 2005; 105: 3871-4.
158. Gekas C, Rhodes KE, Gereige LM, et al. Mef2C is a lineage-restricted target of Scl/Tal1 and regulates megakaryopoiesis and B-cell homeostasis. Blood 2009; 113: 3461-71.
159. Brunet de la Grange P, Armstrong F, Duval V, et al. LowSCL/TAL1 expression reveals its major role in adult hematopoietic myeloid progenitors and stem cells. Blood 2006; 108: 2998-3004.
160. Brunet de la Grange P, Zink E, Armstrong F, Rouyez MC, Pflumio F. Impairment of granulo-monocytic development of human common myeloid progenitors but not of granulo-monocytic progenitors by decreasing stem cell leukemia/T-cell acute leukemia 1 expression. Stem Cells 2008; 26: 1658-62.
161. Wadman I, Li J, Bash RO, et al. Specific in vivo association between the bHLH and LIM proteins implicated in human T cell leukemia. EMBO J 1994; 13: 4831-9.
162. Wadman IA, Osada H, Grutz GG, et al. The LIM-only proteinLmo2 is a bridging molecule assembling an erythroid, DNA binding complex which includes the TAL1, E47, GATA-1 and Ldb1/NLI proteins. EMBO J 1997; 16: 3145-57.
163. Landry JR, Bonadies N, Kinston S, et al. Expression of the leukemia oncogene Lmo2 is controlled by an array of tissue-specific elements dispersed over 100 kb and bound by Tal1/Lmo2, Ets, and Gata factors. Blood 2009; 113: 5783-92.
164. Boehm T, Foroni L, Kaneko Y, Perutz MF, Rabbitts TH. The rhombotin family of cysteine-rich LIM-domain oncogenes: distinct members are involved in T-cell translocations to human chromosomes 11p15 and 11p13. Proc Natl Acad Sci USA 1991; 88: 4367-71.
165. Mead PE, Deconinck AE, Huber TL, Orkin SH, Zon LI. Primitive erythropoiesis in the Xenopus embryo: the synergistic role ofLMO-2, SCL and GATA-binding proteins. Development 2001;128: 2301-8.
166. Mead PE, Kelley CM, Hahn PS, Piedad O, Zon LI. SCL specifies hematopoietic mesoderm in Xenopus embryos. Development 1998;125: 2611-20.
167. Felli N, Pedini F, Romania P, et al. MicroRNA 223-dependent expression of LMO2 regulates normal erythropoiesis. Haematologica 2009; 94: 479-86.
168. Goardon N, Lambert JA, Rodriguez P, et al. ETO2 coordinates cellular proliferation and differentiation during erythropoiesis. EMBO J 2006; 25: 357-66.
169. Hu X, Li X, Valverde K, et al. LSD1-mediated epigenetic modification is required for TAL1 function and hematopoiesis. Proc Natl Acad Sci USA 2009; 106: 10141-6.
170. Drissen R, von Lindern M, Kolbus A, et al. The erythroid phenotype of EKLF-null mice: defects in hemoglobin metabolism and membrane stability. Mol Cell Biol 2005; 25: 5205-14.
171. Gregory RC, Taxman DJ, Seshasayee D, Kensinger MH, Bieker JJ, Wojchowski DM. Functional interaction of GATA1 with erythroid Kruppel-like factor and Sp1 at defined erythroid promoters. Blood 1996; 87: 1793-801.
172. Orkin SH, Kazazian HH, Jr., Antonarakis SE, et al. Linkage of beta-thalassaemia mutations and beta-globin gene polymorphisms with DNA polymorphisms in human beta-globin gene cluster. Nature 1982; 296: 627-31.
173. Nuez B, Michalovich D, Bygrave A, Ploemacher R, Grosveld F.Defective haematopoiesis in fetal liver resulting from inactivation of the EKLF gene. Nature 1995; 375: 316-8.
174. Perkins AC, Sharpe AH, Orkin SH. Lethal beta-thalassaemia in mice lacking the erythroid CACCC-transcription factor EKLF. Nature 1995; 375: 318-22.
175. Tallack MR, Perkins AC. Megakaryocyte-erythroid lineage promiscuity in EKLF null mouse blood. Haematologica 2010; 95(1):144-7.
176. Hodge D, Coghill E, Keys J, et al. A global role for EKLF in definitive and primitive erythropoiesis. Blood 2006; 107: 3359-70.
177. Pilon AM, Arcasoy MO, Dressman HK, et al. Failure of terminalery throid differentiation in EKLF-deficient mice is associated with cell cycle perturbation and reduced expression of E2F2. Mol Cell Biol 2008; 28: 7394-401.
178. Tallack MR, Keys JR, Humbert PO, Perkins AC. EKLF/KLF1 controls cell cycle entry via direct regulation of E2f2. J Biol Chem 2009; 284: 20966-74.
179. Siatecka M, Xue L, Bieker JJ. Sumoylation of EKLF promotes transcriptional repression and is involved in inhibition of megakaryopoiesis. Mol Cell Biol 2007; 27: 8547-60.
180. Duan Z, Horwitz M. Gfi-1 oncoproteins in hematopoiesis. Hematology 2003; 8: 339-44.
181. Vassen L, Okayama T, Moroy T. Gfi1b: green fluorescent protein knock-in mice reveal a dynamic expression pattern of Gfi1b during hematopoiesis that is largely complementary to Gfi1. Blood 2007;109: 2356-64.
182. Saleque S, Cameron S, Orkin SH. The zinc-finger proto-oncogene Gfi-1b is essential for development of the erythroid and megakaryocytic lineages. Genes Dev 2002; 16: 301-6.
183. Osawa M, Yamaguchi T, Nakamura Y, Kaneko S, Onodera M, Sawada K, et al. Erythroid expansion mediated by the Gfi-1B zinc finger protein: role in normal hematopoiesis. Blood 2002; 100:2769-77.
184. Jegalian AG, Wu H. Regulation of Socs gene expression by the proto-onco protein GFI-1B: two routes for STAT5 target gene induction by erythropoietin. J Biol Chem 2002; 277: 2345-52.
185. Tong B, Grimes HL, Yang TY, et al. The Gfi-1B proto-onco protein represses p21WAF1 and inhibits myeloid cell differentiation. Mol Cell Biol 1998; 18: 2462-73.
186. Kuo YY, Chang ZF. GATA-1 and Gfi-1B interplay to regulate BclxL transcription. Mol Cell Biol 2007; 27: 4261-72.
187. Saleque S, Kim J, Rooke HM, Orkin SH. Epigenetic regulation of hematopoietic differentiation by Gfi-1 and Gfi-1b is mediated by the cofactors CoREST and LSD1. Mol Cell 2007; 27: 562-72.
188. Huang DY, Kuo YY, Chang ZF. GATA-1 mediates auto-regulation of Gfi-1B transcription in K562 cells. Nucleic Acids Res 2005; 33:5331-42.
189. Anguita E, Villegas A, Iborra F, Hernandez A. Gfi1b controls its own expression binding to multiple sites. Haematologica 2009;
190. Vassen L, Fiolka K, Mahlmann S, Moroy T. Direct transcriptional repression of the genes encoding the zinc-finger proteins Gfi1b andGfi1 by Gfi1b. Nucleic Acids Res 2005; 33: 987-98.
191. Laurent B, Randrianarison-Huetz V, Marechal V, Mayeux P, Dusanter-Fourt I, Dumenil D. High Mobility Group protein HMGB2regulates human erythroid differentiation through trans-activation of Gfi-1B transcription. Blood 2010; 115(3): 687-95.
192. Andrews NC, Kotkow KJ, Ney PA, Erdjument-Bromage H, Tempst P, Orkin SH. The ubiquitous subunit of erythroid transcription factor NF-E2 is a small basic-leucine zipper protein related to the v-maf oncogene. Proc Natl Acad Sci USA 1993; 90: 11488-92.
193. Ney PA, Sorrentino BP, Lowrey CH, Nienhuis AW. Inducibility of the HS II enhancer depends on binding of an erythroid specific nuclear protein. Nucleic Acids Res 1990; 18: 6011-7.
194. Ney PA, Andrews NC, Jane SM, et al. Purification of the humanNF-E2 complex: cDNA cloning of the hematopoietic cell-specific subunit and evidence for an associated partner. Mol Cell Biol 1993;13: 5604-12.
195. Taketani S, Inazawa J, Nakahashi Y, Abe T, Tokunaga R. Structure of the human ferrochelatase gene. Exon/intron gene organization and location of the gene to chromosome 18. Eur J Biochem 1992;205: 217-22.
196. Gong QH, McDowell JC, Dean A. Essential role of NF-E2 in remodeling of chromatin structure and transcriptional activation of the epsilon-globin gene in vivo by 5' hypersensitive site 2 of the beta-globin locus control region. Mol Cell Biol 1996; 16: 6055-64.
197. Deveaux S, Cohen-Kaminsky S, Shivdasani RA, et al. p45 NF-E2regulates expression of thromboxane synthase in megakaryocytes. EMBO J 1997; 16: 5654-61.
198. Shivdasani RA, Orkin SH. Erythropoiesis and globin gene expression in mice lacking the transcription factor NF-E2. Proc Natl Acad Sci USA 1995; 92: 8690-4.
199. Levin J, Peng JP, Baker GR, et al. Pathophysiology of thrombocytopenia and anemia in mice lacking transcription factor NF-E2. Blood 1999; 94: 3037-47.
200. Fock EL, Yan F, Pan S, Chong BH. NF-E2-mediated enhancement of megakaryocytic differentiation and platelet production in vitro and in vivo. Exp Hematol 2008; 36: 78-92.
201. Kotkow KJ, Orkin SH. Dependence of globin gene expression inmouse erythroleukemia cells on the NF-E2 heterodimer. Mol Cell Biol 1995; 15: 4640-7.
202. Shavit JA, Motohashi H, Onodera K, Akasaka J, Yamamoto M,Engel JD. Impaired megakaryopoiesis and behavioral defects in mafG-null mutant mice. Genes Dev 1998; 12: 2164-74.
203. Onodera K, Shavit JA, Motohashi H, Yamamoto M, Engel JD. Perinatal synthetic lethality and hematopoietic defects in compound mafG: mafK mutant mice. EMBO J 2000; 19: 1335-45.
204. Lecine P, Italiano JE, Jr., Kim SW, Villeval JL, Shivdasani RA. Hematopoietic-specific beta 1 tubulin participates in a pathway of platelet biogenesis dependent on the transcription factor NF-E2. Blood 2000; 96: 1366-73.
205. Tiwari S, Italiano JE, Jr., Barral DC, et al. A role for Rab27b inNF-E2-dependent pathways of platelet formation. Blood 2003; 102:3970-9.
206. Nagata Y, Yoshikawa J, Hashimoto A, Yamamoto M, Payne AH, Todokoro K. Proplatelet formation of megakaryocytes is triggered by auto crine-synthesized estradiol. Genes Dev 2003; 17: 2864-9.
207. Motohashi H, Kimura M, Fujita R, et al. NF-E2 domination over Nrf2 promotes ROS accumulation and megakaryocytic maturation. Blood 2010; 115(3): 677-86.
208. Gronostajski RM. Roles of the NFI/CTF gene family in transcription and development. Gene 2000; 249: 31-45.
209. Roulet E, Bucher P, Schneider R, et al. Experimental analysis and computer prediction of CTF/NFI transcription factor DNA binding sites. J Mol Biol 2000; 297: 833-48.
210. Bedford FK, Julius D, Ingraham HA. Neuronal expression of the5HT3 serotonin receptor gene requires nuclear factor 1 complexes. J Neurosci 1998; 18: 6186-94.
211. Spitz F, Salminen M, Demignon J, Kahn A, Daegelen D, Maire P.A combination of MEF3 and NFI proteins activates transcription ina subset of fast-twitch muscles. Mol Cell Biol 1997; 17: 656-66.
212. Bachurski CJ, Kelly SE, Glasser SW, Currier TA. Nuclear factor I family members regulate the transcription of surfactant protein-C. J Biol Chem 1997; 272: 32759-66.
213. Jackson DA, Rowader KE, Stevens K, Jiang C, Milos P, Zaret KS. Modulation of liver-specific transcription by interactions between hepatocyte nuclear factor 3 and nuclear factor 1 binding DNA in close apposition. Mol Cell Biol 1993; 13: 2401-10.
214. Leahy P, Crawford DR, Grossman G, Gronostajski RM, Hanson RW. CREB binding protein coordinates the function of multiple transcription factors including nuclear factor I to regulate phos-phoenolpyruvate carboxykinase (GTP) gene transcription. J Biol Chem 1999; 274: 8813-22.
215. Fazi F, Rosa A, Fatica A, et al. A minicircuitry comprised of microRNA-223 and transcription factors NFI-A and C/EBPalpha regulates human granulopoiesis. Cell 2005; 123: 819-31.
216. Starnes LM, Sorrentino A, Pelosi E, et al. NFI-A directs the fate of hematopoietic progenitors to the erythroid or granulocytic lineage and controls beta-globin and G-CSF receptor expression. Blood 2009; 114: 1753-63.
217. Felli N, Fontana L, Pelosi E, et al. MicroRNAs 221 and 222 inhibit normal erythropoiesis and erythroleukemic cell growth via kit receptor down-modulation. Proc Natl Acad Sci USA 2005; 102:18081-6.
218. Kent D, Copley M, Benz C, Dykstra B, Bowie M, Eaves C. Regulation of hematopoietic stem cells by the steel factor/KIT signaling pathway. Clin Cancer Res 2008; 14: 1926-30.
219. Wang Q, Huang Z, Xue H, et al. MicroRNA miR-24 inhibit serythropoiesis by targeting active in type I receptor ALK4. Blood 2008; 111: 588-95.
220. O'Carroll D, Mecklenbrauker I, Das PP, et al. A Slicer-independent role for Argonaute 2 in hematopoiesis and the microRNA pathway. Genes Dev 2007; 21: 1999-2004.
221. Garzon R, Pichiorri F, Palumbo T, et al. MicroRNA fingerprints during human megakaryocytopoiesis. Proc Natl Acad Sci USA 2006; 103: 5078-83.
222. Labbaye C, Spinello I, Quaranta MT, et al. A three-step pathway comprising PLZF/miR-146a/CXCR4 controls megakaryopoiesis. Nat Cell Biol 2008; 10: 788-801.
223. Romania P, Lulli V, Pelosi E, Biffoni M, Peschle C, Marziali G. MicroRNA 155 modulates megakaryopoiesis at progenitor and precursor level by targeting Ets-1 and Meis1 transcription factors. Br J Haematol 2008; 143: 570-80.
224. Pendaries C, Watson SP, Spalton JC. Methods for genetic modification of megakaryocytes and platelets. Platelets 2007; 18: 393-408.
225. Skalnik DG. Transcriptional mechanisms regulating myeloid-specific genes. Gene 2002; 284: 1-21.
226. Huang G, Zhang P, Hirai H, et al. PU.1 is a major downstream target of AML1 (RUNX1) in adult mouse hematopoiesis. Nat Genet 2008; 40: 51-60.
227. DeKoter RP, Singh H. Regulation of B lymphocyte and macrophage development by graded expression of PU.1. Science 2000;288: 1439-41.
228. Feng R, Desbordes SC, Xie H, et al. PU.1 and C/EBPalpha/beta convert fibroblasts into macrophage-like cells. Proc Natl Acad Sci USA 2008; 105: 6057-62.
229. Scott EW, Simon MC, Anastasi J, Singh H. Requirement of transcriptionfactor PU.1 in the development of multiple hematopoietic lineages. Science 1994; 265: 1573-7.
230. McKercher SR, Torbett BE, Anderson KL, et al. Targeted disruption of the PU.1 gene results in multiple hematopoietic abnormalities. EMBO J 1996; 15: 5647-58.
231. Metcalf D, Dakic A, Mifsud S, Di Rago L, Wu L, Nutt S. Inactivation of PU.1 in adult mice leads to the development of myeloidleukemia. Proc Natl Acad Sci USA 2006; 103: 1486-91.
232. Pahl HL, Scheibe RJ, Zhang DE, et al. The proto-oncogene PU.1 regulates expression of the myeloid-specific CD11b promoter. J Biol Chem 1993; 268: 5014-20.
233. Zhang DE, Hetherington CJ, Chen HM, Tenen DG. The macrophage transcription factor PU.1 directs tissue-specific expression of the macrophage colony-stimulating factor receptor. Mol Cell Biol 1994; 14: 373-81.
234. Smith LT, Hohaus S, Gonzalez DA, Dziennis SE, Tenen DG. PU.1(Spi-1) and C/EBP alpha regulate the granulocyte colony stimulating factor receptor promoter in myeloid cells. Blood 1996;88: 1234-47.
235. Hohaus S, Petrovick MS, Voso MT, Sun Z, Zhang DE, Tenen DG. PU.1 (Spi-1) and C/EBP alpha regulate expression of the granulocyte-macrophage colony-stimulating factor receptor alpha gene. Mol Cell Biol 1995; 15: 5830-45.
236. Krysinska H, Hoogenkamp M, Ingram R, et al. A two-step, PU.1-dependent mechanism for developmentally regulated chromatinre modeling and transcription of the c-fms gene. Mol Cell Biol 2007; 27: 878-87.
237. Henkel GW, McKercher SR, Leenen PJ, Maki RA. Commitment to the monocytic lineage occurs in the absence of the transcription factor PU.1. Blood 1999; 93: 2849-58.
238. Lord KA, Abdollahi A, Hoffman-Liebermann B, Liebermann DA. Proto-oncogenes of the fos/jun family of transcription factors arepositive regulators of myeloid differentiation. Mol Cell Biol 1993;13: 841-51.
239. Rosa A, Ballarino M, Sorrentino A, et al. The interplay between the master transcription factor PU.1 and miR-424 regulates human monocyte/macrophage differentiation. Proc Natl Acad Sci USA 2007; 104: 19849-54.
240. De Marchis ML, Ballarino M, Salvatori B, Puzzolo MC, Bozzoni I, Fatica A. A new molecular network comprising PU.1, interferon regulatory factor proteins and miR-342 stimulates ATRA-mediated granulocytic differentiation of acute promyelocytic leukemia cells. Leukemia 2009; 23: 856-62.
241. O'Connell RM, Taganov KD, Boldin MP, Cheng G, Baltimore D. MicroRNA-155 is induced during the macrophage inflammatory response. Proc Natl Acad Sci USA 2007; 104: 1604-9.
242. O'Connell RM, Rao DS, Chaudhuri AA, et al. Sustained expression of microRNA-155 in hematopoietic stem cells causes a myeloproliferative disorder. J Exp Med 2008; 205: 585-94.
243. Eis PS, Tam W, Sun L, et al. Accumulation of miR-155 and BICRNA in human B cell lymphomas. Proc Natl Acad Sci U SA 2005;102: 3627-32.
244. Costinean S, Zanesi N, Pekarsky Y, et al. Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in E(mu)-miR155 transgenic mice. Proc Natl Acad Sci USA 2006; 103:7024-9.
245. Ebralidze AK, Guibal FC, Steidl U, Zhang P, Lee S, Bartholdy B, et al. PU.1 expression is modulated by the balance of functional sense and antisense RNAs regulated by a shared cis-regulatory element. Genes Dev 2008; 22: 2085-92.
246. Scott LM, Civin CI, Rorth P, Friedman AD. A novel temporal expression pattern of three C/EBP family members in differentiating myelomonocytic cells. Blood 1992; 80: 1725-35.
247. Zhang DE, Zhang P, Wang ND, Hetherington CJ, Darlington GJ, Tenen DG. Absence of granulocyte colony-stimulating factor signaling and neutrophil development in CCAAT enhancer binding protein alpha-deficient mice. Proc Natl Acad Sci USA 1997; 94:569-74.
248. Dahl R, Walsh JC, Lancki D, et al. Regulation of macrophage and neutrophil cell fates by the PU.1:C/EBPalpha ratio and granulocyte colony-stimulating factor. Nat Immunol 2003; 4: 1029-36.
249. Fukao T, Fukuda Y, Kiga K, et al. An evolutionarily conserved mechanism for microRNA-223 expression revealed by microRNA gene profiling. Cell 2007; 129: 617-31.
250. Johnnidis JB, Harris MH, Wheeler RT, et al. Regulation of progenitor cell proliferation and granulocyte function by microRNA-223. Nature 2008; 451: 1125-9.
251. Gentner B, Schira G, Giustacchini A, et al. Stable knockdown of microRNA in vivo by lentiviral vectors. Nat Methods 2009; 6: 63-6.
252. Stehling-Sun S, Dade J, Nutt SL, DeKoter RP, Camargo FD. Regulation of lymphoid versus myeloid fate 'choice' by the transcription factor Mef2c. Nat Immunol 2009; 10: 289-96.
253. Schuler A, Schwieger M, Engelmann A, et al. The MADS transcription factor Mef2c is a pivotal modulator of myeloid cell fate. Blood 2008; 111: 4532-41.
254. Baek D, Villen J, Shin C, Camargo FD, Gygi SP, Bartel DP. The impact of microRNAs on protein output. Nature 2008; 455: 64-71.
255. Pulikkan JA, Dengler V, Paramangalam PS, et al. Cell cycle regulator E2F1 and microRNA-223 comprise an autoregulatory negative feedback loop in acute myeloid leukemia. Blood 2010; 115(9):1768-78.
256. Fazi F, Racanicchi S, Zardo G, et al. Epigenetic silencing of the myelopoiesis regulator microRNA-223 by the AML1/ETO oncoprotein. Cancer Cell 2007; 12: 457-66.
257. Tanaka T, Akira S, Yoshida K, et al. Targeted disruption of the NF-IL6 gene discloses its essential role in bacteria killing and tumor cytotoxicity by macrophages. Cell 1995; 80: 353-61.
258. Pizarro-Cerda J, Desjardins M, Moreno E, Akira S, Gorvel JP. Modulation of endocytosis in nuclear factor IL-6(-/-) macrophagesis responsible for a high susceptibility to intracellular bacterial infection. J Immunol 1999; 162: 3519-26.
259. Screpanti I, Romani L, Musiani P, et al. Lymphoproliferative disorder and imbalanced T-helper response in C/EBP beta-deficient mice. EMBO J 1995; 14: 1932-41.
260. Akagi T, Saitoh T, O'Kelly J, Akira S, Gombart AF, Koeffler HP. Impaired response to GM-CSF and G-CSF, and enhanced apoptosis in C/EBP beta-deficient hematopoietic cells. Blood 2008; 111:2999-3004.
261. Plachetka A, Chayka O, Wilczek C, Melnik S, Bonifer C, Klempnauer KH. C/EBPbeta induces chromatin opening at a cell-type specific enhancer. Mol Cell Biol 2008; 28: 2102-12.
262. Yamanaka R, Kim GD, Radomska HS, et al. CCAAT/enhancer binding protein epsilon is preferentially up-regulated during granulocytic differentiation and its functional versatility is determined by alternative use of promoters and differential splicing. Proc Natl Acad Sci USA 1997; 94: 6462-7.
263. Yamanaka R, Barlow C, Lekstrom-Himes J, et al. Impaired granulopoiesis, myelodysplasia, and early lethality in CCAAT/enhancer binding protein epsilon-deficient mice. Proc Natl Acad Sci USA 1997; 94: 13187-92.
264. Lekstrom-Himes JA, Dorman SE, Kopar P, Holland SM, Gallin JI. Neutrophil-specific granule deficiency results from a novel mutation with loss of function of the transcription factor CCAAT/enhancer binding protein epsilon. J Exp Med 1999; 189:1847-52.
265. Verbeek W, Wachter M, Lekstrom-Himes J, Koeffler HP. C/EBPepsilon -/- mice: increased rate of myeloid proliferation andapoptosis. Leukemia 2001; 15: 103-11.
266. Verbeek W, Lekstrom-Himes J, Park DJ, et al. Myeloid transcription factor C/EBPepsilon is involved in the positive regulation of lactoferrin gene expression in neutrophils. Blood 1999; 94: 3141-50.
267. Park DJ, Chumakov AM, Vuong PT, et al. CCAAT/enhancer binding protein epsilon is a potential retinoid target gene in acute promyelocytic leukemia treatment. J Clin Invest 1999; 103: 1399-408.
268. Hock H, Hamblen MJ, Rooke HM, et al. Intrinsic requirement for zinc finger transcription factor Gfi-1 in neutrophil differentiation. Immunity 2003; 18: 109-20.
269. Karsunky H, Mende I, Schmidt T, Moroy T. High levels of the onco-protein Gfi-1 accelerate T-cell proliferation and inhibit activation induced T-cell death in Jurkat T-cells. Oncogene 2002; 21:1571-9.
270. Duan Z, Horwitz M. Targets of the transcriptional repressor oncoprotein Gfi-1. Proc Natl Acad Sci USA 2003; 100: 5932-7.
271. Dahl R, Iyer SR, Owens KS, Cuylear DD, Simon MC. The transcriptional repressor GFI-1 antagonizes PU.1 activity through protein-protein interaction. J Biol Chem 2007; 282: 6473-83.
272. Horman SR, Velu CS, Chaubey A, et al. Gfi1 integrates progenitor versus granulocytic transcriptional programming. Blood 2009; 113:5466-75.
273. Velu CS, Baktula AM, Grimes HL. Gfi1 regulates miR-21 andmiR-196b to control myelopoiesis. Blood 2009; 113: 4720-8.
274. McConnell MJ, Licht JD. The PLZF gene of t (11;17)-associated APL. Curr Top Microbiol Immunol 2007; 313: 31-48.
275. Reid A, Gould A, Brand N, et al. Leukemia translocation gene, PLZF, is expressed with a speckled nuclear pattern in early hematopoietic progenitors. Blood 1995; 86: 4544-52.
276. Shaknovich R, Yeyati PL, Ivins S, et al. The promyelocytic leukemiazinc finger protein affects myeloid cell growth, differentiation, and apoptosis. Mol Cell Biol 1998; 18: 5533-45.
277. Ward JO, McConnell MJ, Carlile GW, Pandolfi PP, Licht JD, Freedman LP. The acute promyelocytic leukemia-associated protein, promyelocytic leukemia zinc finger, regulates 1,25-dihydroxyvitamin D(3)-induced monocytic differentiation of U937cells through a physical interaction with vitamin D(3) receptor. Blood 2001; 98: 3290-300.
278. Doulatov S, Notta F, Rice KL, et al. PLZF is a regulator of homeostatic and cytokine-induced myeloid development. Genes Dev 2009; 23: 2076-87.
279. Kelly LM, Englmeier U, Lafon I, Sieweke MH, Graf T. MafB is an inducer of monocytic differentiation. EMBO J 2000; 19: 1987-97.
280. Tillmanns S, Otto C, Jaffray E, et al. SUMO modification regulates MafB-driven macrophage differentiation by enabling Myb dependent transcriptional repression. Mol Cell Biol 2007; 27:5554-64.
281. Blanchi B, Kelly LM, Viemari JC, et al. MafB deficiency causes defective respiratory rhythmogenesis and fatal central apnea at birth. Nat Neurosci 2003; 6: 1091-100.
282. Aziz A, Vanhille L, Mohideen P, et al. Development of macrophages with altered actin organization in the absence of MafB. Mol Cell Biol 2006; 26: 6808-18.
283. Sarrazin S, Mossadegh-Keller N, Fukao T, et al. MafB restricts MCSF-dependent myeloid commitment divisions of hematopoietic stem cells. Cell 2009; 138: 300-13.
284. Aziz A, Soucie E, Sarrazin S, Sieweke MH. MafB/c-Maf deficiency enables self-renewal of differentiated functional macrophages. Science 2009; 326: 867-71.
285. Sorrentino A, Liu CG, Addario A, Peschle C, Scambia G, Ferlini C. Role of microRNAs in drug-resistant ovarian cancer cells. Gynecol Oncol 2008; 111: 478-86.
286. Fujimoto T, Anderson K, Jacobsen SE, Nishikawa SI, Nerlov C. Cdk6 blocks myeloid differentiation by interfering with Runx1DNA binding and Runx1-C/EBPalpha interaction. EMBO J 2007;26: 2361-70.
287. Fontana L, Pelosi E, Greco P, et al. MicroRNAs 17-5p-20a-106acontrol monocytopoiesis through AML1 targeting and M-CSF receptor up regulation. Nat Cell Biol 2007; 9: 775-87.
288. Feng J, Iwama A, Satake M, Kohu K. MicroRNA-27 enhances differentiation of myeloblasts into granulocytes by post-transcriptionally down regulating Runx1. Br J Haematol 2009; 145:412-23.
289. Gandillet A, Serrano AG, Pearson S, Lie-A-Ling M, Lacaud G, Kouskoff V. Sox7-sustained expression alters the balance between proliferation and differentiation of hematopoietic progenitors at the onset of blood specification. Blood 2009; 23: 4813-22.
290. Hock H, Hambien MJ, Rooke HM, et al. Gfi-1 restricts proliferation and preserves functional integrity of haematopoietic stem cells. Nature 2004; 7011: 1002-7.
291. Galan-Caridad JM, Harel S, Arenzana TL, et al. Zfx controls the self-renewal of embryonic and hematopoietic stem cells. Cell 2007;2: 345-57.
292. Sun Y, Shao L, Bai H, Wang ZZ, Wu WS. Slug deficiency enhances self-renewal of hematopoietic stem cells during hematopoieticre generation. Blood 2010; 115(9): 1709-17.
293. Jude CD, Climer L, Xu D, Artinger E, Fisher JK, Ernst P. Unique and independent roles for MLL in adult hematopoietic stem cells and progenitors. Cell Stem Cell 2007; 3: 324-37.
294. Madan V, Madan B, Brykczynska U, et al. Impaired function of primitive hematopoietic cells in mice lacking the Mixed-Lineage-Leukemia homolog MLL5. Blood 2009; 7: 1444-54.
295. Zhang Y, Wong J, Klinger M, Tran MT, Shannon KM, Killeen N. MLL5 contributes to hematopoietic stem cell fitness and homeostasis. Blood 2009; 7: 1455-63.
296. Yoshida T, Hazan I, Zhang J, et al. The role of the chromatin remodelerMi-2β in hematopoietic stem cell self-renewal and multilineagedifferentiation. Genes Dev 2008; 22: 1174-1189.
297. Park IK, Qian D, Kiel M, et al. Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells. Nature 2003;6937: 302-5.
298. Kajiume T, Ninomiya Y, Ishihara H, Kanno R, Kanno M. Polycomb group gene mel-18 modulates the self-renewal activity andcell cycle status of hematopoietic stem cells. Exp Hematol 2004; 6:571-8.
299. Kim JY, Sawada A, Tokimasa S, et al. Defective long-term repopulating ability in hematopoietic stem cells lacking the Polycomb group gene rae28. Eur J Hematol 2004; 2: 75-84.
300. Majewski IJ, Blewitt ME, de Graaf CA, et al. Polycomb repressive complex 2 (PRC2) restricts hematopoietic stem cell activity. PLoS Biol 2008; 4: e93.
301. Kamminga LM, Bystrykh LV, de Boer A, et al. The Polycom bgroup gene Ezh2 prevents hematopoietic stem cell exhaustion. Blood 2006; 5: 2170-9.
302. Kranc KR, Schepers H, Rodrigues NP, et al. Cited2 is an essential regulator of adult hematopoietic stem cells. Cell Stem Cell 2009; 6:659-65.
303. Laurenti E, Varnum-Finney B, Wilson A, et al. Hematopoietic stem cell function and survival depend on c-Myc and N-Myc activity. Cell Stem Cell 2008; 6: 611-24.
304. Wilson A, Murphy MJ, Oskarsson T, et al. c-Myc controls the balance between hematopoietic stem cell self-renewal and differentiation. Genes Dev 2004; 22: 2747-63.
305. Lacorazza HD, Yamada T, Liu Y, et al. The transcription factor MEF/ELF4 regulates the quiescence of primitive hematopoietic cells. Cancer Cell 2006; 3: 175-87.
306. Liu Y, Elf SE, Miyata Y, al. Regulates hematopoietic stem cell quiescence. Cell Stem Cell 2009; 1: 37-48.
307. Jankovic V, Ciarocchi A, Boccuni P, DeBlasio T, Benezra R, Nimer SD. Id1 restrains myeloid commitment, maintaining the self renewal capacity of hematopoietic stem cells. Proc Natl Acad Sci USA 2007; 4: 1260-5.
308. Pina C, May G, Soneji S, Hong D, Enver T. MLLT3 regulates early human erythroid and megakaryocytic cell fate. Cell Stem Cell 2008; 3: 264-73.
309. Sankaran VG, Menne TF, Xu J, et al. Human fetal hemoglobin expression is regulated by the developmental stage-specific repressor BCL11A. Science 2008; 5909: 1839-42.
310. Sankaran VG, Orkin SH, Walkley CR. Rb intrinsically promotes erythropoiesis by coupling cell cycle exit with mitochondrial biogenesis. Genes Dev 2008; 4: 463-75.
311. Iavarone A, King ER, Dai XM, Leone G, Stanley ER, Lasorella A. Retinoblastoma promotes definitive erythropoiesis by repressing Id2 in fetal liver macrophages. Nature 2004; 7020: 1040-5.
312. Ji M, Li H, Suh HC, Klarmann KD, Yokota Y, Keller JR. Id2 intrinsically regulates lymphoid and erythroid development via interaction with different target proteins. Blood 2008; 4: 1068-77.
313. Labbaye C, Quaranta MT, Pagliuca A, et al. PLZF induces megakaryocytic developmenty, activates Tpo receptor expression and interacts with GATA1 protein. Oncogene 2002; 43: 6669-79.
314. Guo Y, Niu C, Breslin P, et al. c-Myc-mediated control of cell fatein megakaryocyte-erythrocyte progenitors. Blood 2009; 10: 2097-106.
315. Bianchi N, Zuccato G, Lampronti I, Borgatti M, Gambari R. Expression of miR-210 during erythroid differentiation and induction of gamma-globin gene expression. BMB Rep 2009; 8: 493-9.
316. Buitenhuis M, van Deutekom HW, Verhangen LP, et al. Differentialregulation of granulopoiesis by the basic helix-loop-helix transcriptional inhibitors Id1 and Id2. Blood 2005; 11: 4272-81.
317. Sharabi AB, Aldrich M, Sosic D, et al. Twist-2 controls myeloidlineage development and function. PLoS Biol 2008; 12: e316.